Oncolytics Biotech Inc ONCY Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)
Total Assets	44.45M	40.24M	37.33M	35.33M	31.97M	46.09M	38.82M	34.75M
Total Current Assets	43.54M	39.41M	35.68M	34.26M	31M	45.34M	38.17M	33.38M
Cash and Equivalents	39.48M	33.69M	11.67M	15.87M	17.52M	39.98M	34.91M	29.6M
Total Non-Current Assets	806k	784k	1.71M	566k	863k	598k	564k	301k
Total Liabilities	9.43M	9.47M	10.83M	9.58M	9.73M	17.07M	11.26M	11.78M
Total Current Liabilities	2.42M	2.54M	3.95M	2.47M	2.65M	10.02M	4.24M	4.1M
Total Non-Current Liabilities	7.28M	7.11M	7.04M	7.49M	7.42M	7.38M	7.31M	8.63M
Common Equity	400.12M	396.81M	404.04M	409.41M	413.42M	428.83M	430.91M	432.51M
Retained Earnings	-400.19M	-405.29M	-418.25M	-424.69M	-432.13M	-442.05M	-446M	-452.9M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)
Total Assets	14.76M	18.15M	14.87M	19.66M	34.35M	45.88M	37.33M	38.82M
Total Current Assets	14.44M	17.82M	14.45M	18.93M	33.74M	44.9M	35.68M	38.17M
Cash and Equivalents	12.03M	11.84M	13.7M	14.15M	31.22M	41.26M	11.67M	34.91M
Total Non-Current Assets	10.69M	8.28M	6.2M	-108k	24.75M	36.1M	26.5M	27.56M
Total Liabilities	4.07M	9.87M	8.67M	19.77M	9.59M	9.78M	10.83M	11.26M
Total Current Liabilities	4.07M	5.23M	2.82M	12.87M	2.71M	2.69M	3.95M	4.24M
Total Non-Current Liabilities	0	4.64M	5.86M	7.06M	7.04M	7.45M	7.04M	7.31M
Total Equity	10.69M	8.28M	6.2M	-108k	24.75M	36.1M	26.5M	27.56M
Common Equity	262.32M	275.33M	288.81M	314.7M	360.44M	394.97M	404.04M	430.91M
Retained Earnings	-278.83M	-294.45M	-311.48M	-344.61M	-367.11M	-393.42M	-418.25M	-446M